Panaxia Labs Israel (XTAE:PNAX) 3-Year Revenue Growth Rate : -37.60% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Panaxia Labs Israel 3-Year Revenue Growth Rate?

Panaxia Labs Israel's Revenue per Share for the three months ended in Dec. 2023 was ₪0.00.

During the past 12 months, Panaxia Labs Israel's average Revenue per Share Growth Rate was -50.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was -37.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 18.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Panaxia Labs Israel was 390.00% per year. The lowest was -37.60% per year. And the median was 69.75% per year.

Competitive Comparison of Panaxia Labs Israel's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Panaxia Labs Israel's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panaxia Labs Israel's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panaxia Labs Israel's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Panaxia Labs Israel's 3-Year Revenue Growth Rate falls into.

Panaxia Labs Israel 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Panaxia Labs Israel (XTAE:PNAX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Panaxia Labs Israel 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Panaxia Labs Israel's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Panaxia Labs Israel (XTAE:PNAX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Panaxia Labs Israel Ltd (XTAE:PNAX) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jabotinsky Street 7, Ramat Gan, ISR, 52520

Website

https://www.panaxia.co.il

Panaxia Labs Israel Ltd is engaged in the manufacture and distribution of medical cannabis products. The firm offers a wide range of products comprising oral tablets, sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches.

Panaxia Labs Israel (XTAE:PNAX) Headlines

No Headlines